Joint Symposium for International Association on Gnotobiology & Society for Microbial Ecology & Disease Stockholm, Sweden May 28–30, 2008

Table

Functional genomics & the normal flora	Animal models for gastrointestinal functional studies. S Kamiya (Japan)Intestinal flora composition. E Zoetendal (The Netherlands)Intestinal flora function. T Midtvedt (Sweden)Molecular fingerprinting techniques of the intestinal microbiome. L Engstrand (Sweden)
Metabolomics	Understanding the microbial-mammalian cross-talk. J Nicholson (UK)Microbial bile acid metabolism. P Hylemon (USA)Microbial nitrogen metabolism. J Lundberg (Sweden)
Intestinal disturbances	Helicobacter pylori – present state of the art. T Wadström (Sweden)IBD/IBS – animal models. S Pettersson (Sweden)
Immunology	The hygien hypothesis – revised. B Björkstén (Sweden)Atophy and allergy in 5 different EU countries – functional aspects. C Edwards (UK)S. aureus and its superantigens – state of the art. A Wold (Sweden)
Innate immunity & intestinal peptides	Intestinal antimicrobial peptides. K Pütsep/M Andersson (Sweden)Intestinal microbial peptides. J Bienenstoch (Canada)Microbial – antimicrobial compounds. M Mikelsaar (Estonia)
Nutrition	Obesity – pediatric aspects. C Marcus (Sweden)Obesity – microbial aspects. F Bäckhed (Sweden)
Cancer	Cancer and steroid receptors – state of the art. J-Å Gustafsson (Sweden)Prostate cancer – state of animal models. M Pollard (USA)Microbial products and Cancer coli – state of the art. I Rowland (UK)
Antibiotics and gene transfer	GMOs – a hazard to whom. T Traavik (Norway)Probiotic GMOs – when will we see them. Lecture from a leading probiotic companyIntestinal gene transfer. T Midtvedt (Sweden)Antibiotics and alterations in flora composition. C-E Nord (Sweden)
Biofilm and medical relevance	Biofilm in the oral cavity. I Olsen (Norway)Biofilm in the GI ract. U Römling (Sweden)
Pre- & Probiotics	Pre-probiotics – State of the art. Industry representativeProbiotics for non-intestinal disturbances. G Reid (Canada)Rules from regulatory agencies – Europe. S Ahrné (Sweden)Rules from regulatory agencies – Japan. S Kamaiya (Japan)Rules from regulatory agencies – Russia. B Schenderov (Russia)Rules from regulatory agencies – Western hemisphere. L Vieira (Brazil)

This is a tentative programme, more Lecturers to be included.

For further information and registration; www.djuronaset.com www.somed.nu www.gnotobiotics.org